Showing results (2161-2170 of 2,940) with videos related to
Sort By:
Pageof 294
Cancer Investigation|June 7, 2026
Quantifying the Mediation Effect of Disease Stage on Racial Disparities in Head and Neck Cancer SurvivalUchechukwu C Megwalu, Yifei MaCancer Investigation|July 24, 2023
In Vitro and In Vivo Synergistic Antitumor Activity of Albumin-Coated Oleic Acid-Loaded Liposomes toward Hepatocellular CarcinomaEsmail M El-Fakharany, Mahmoud Ashry, Marwa M Abu-Serie, et al.Cancer Investigation|July 18, 2023
Neoadjuvant Therapy and Axillary Lymph Node Status in HER2-Positive Breast CancerSabine Danzinger, Christian Pfeifer, Sophia Wimmer, et al.Cancer Investigation|July 25, 2023
A Nomogram for Predicting Survival in Advanced Non-Small-Cell Lung Carcinoma Patients: A Population-Based StudyBo Yang, Mengmeng Teng, Haisheng You, et al.Cancer Investigation|January 12, 2005
Informing the patient about a fatal disease: from paternalism to autonomy--the Jewish viewFred RosnerCancer Investigation|January 1, 1989
Malignant mesotheliomas in Kure City, Japan: the relationship of asbestos exposureT Kishimoto, T Sato, T Ono, et al.Cancer Investigation|August 7, 2001
Development of quantitative structure-activity relationship (QSAR) models for predicting risk of exposure from carcinogens in animalsA K SinghCancer Investigation|July 12, 2026
Sub-National Disparities in the Incidence of Cancers Associated with Modifiable Risk Factors: An Analysis of Canadian CiNA Data (2010-2022)Omar Abdel-RahmanCancer Investigation|June 30, 2026
Analysis of Second Primary Tumours in Cutaneous Lymphoma PopulationsShuaijun Zou, Ruiqian Yao, Xiaoyan Yang, et al.Cancer Investigation|July 5, 2026
Profiling Immune-Related Adverse Events Associated with Imatinib: A Two-Decade Real-World Safety Study Based on FDA Adverse Event Reporting SystemYongfeng Zhu, Yanbin Zeng, Wanlong Lin, et al.Pageof 294